METHYLDOPA Side Effects

6772204-4 | Anaemia Haemolytic Autoimmune
on Jun 01, 2010 Male patient from UNITED KINGDOM , 47 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune. Methyldopa dosage: Oral. Patient was hospitalized.

6750618-6 | Caesarean Section, Premature Baby, Small For Dates Baby
Patient was taking Methyldopa (View Usage). Patient had the following side effects: caesarean section, premature baby, small for dates baby on May 20, 2010 from AUSTRIA Additional patient health information: Female patient , weighting 1.26 lb, . Methyldopa dosage: . During the same period patient was treated with MAGNESIUM (MAGNESIUM) (MAGNESIUM) (View Magnesium (magnesium) (magnesium) Review and Magnesium (magnesium) (magnesium) Label ), PREDNISOLONE (5 Mg) (View Prednisolone Review and Prednisolone Label ), MEZLOCILLINE (MEZLOCILLINE) (MEZLOCILLINE) (View Mezlocilline (mezlocilline) (mezlocilline) Review and Mezlocilline (mezlocilline) (mezlocilline) Label ).

6750616-2 | Caesarean Section, Hepatic Enzyme Abnormal, Platelet Count Decreased, Premature Labour
Adverse event was reported on May 20, 2010 by a Female patient taking Methyldopa (View Usage) (Dosage: ) . Location: AUSTRIA , 33 years of age, After Methyldopa was administered, patient had the following side effects: caesarean section, hepatic enzyme abnormal, platelet count decreased, premature labour. During the same period patient was treated with MAGNESIUM (MAGNESIUM) (MAGNESIUM) (View Magnesium (magnesium) (magnesium) Review and Magnesium (magnesium) (magnesium) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MEZLOCILLIN (MEZLOCILLIN) (MEZLOCILLIN) (View Mezlocillin (mezlocillin) (mezlocillin) Review and Mezlocillin (mezlocillin) (mezlocillin) Label ).

6675525-9 | Somnolence Neonatal
on Mar 31, 2010 Male patient from NETHERLANDS , weighting 6.61 lb, was diagnosed with pregnancy induced hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence neonatal. Methyldopa dosage: .


6656201-5 | Somnolence
on Mar 25, 2010 Male patient from NETHERLANDS , weighting 6.61 lb, was diagnosed with pre-eclampsia and was treated with Methyldopa (View Usage). Patient had the following side effects: somnolence. Methyldopa dosage: .

6538937-X | Foetal Growth Retardation, Hepatitis Acute, Hypertensive Crisis
Patient was taking Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: foetal growth retardation, hepatitis acute, hypertensive crisis on Jan 11, 2010 from CHILE Additional patient health information: Female patient , 36 years of age, was diagnosed with essential hypertension and. Methyldopa dosage: . Patient was hospitalized.

6445635-X | Hallucination, Visual
Adverse event was reported on Nov 18, 2009 by a Female patient taking Methyldopa (View Usage) (Dosage: 25 Mg. 2 Per Day) was diagnosed with hypertension and. Location: UNITED STATES , 67 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: hallucination, visual.

6423786-3 | Abortion Induced, Renal Artery Stenosis
on Sep 09, 2009 Female patient from JAPAN , 25 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: abortion induced, renal artery stenosis. Methyldopa dosage: Oral. During the same period patient was treated with HYDRALAZINE (HYDRALAZINE) (HYDRALAZINE) (View Hydralazine (hydralazine) (hydralazine) Review and Hydralazine (hydralazine) (hydralazine) Label ). Patient was hospitalized.

6423784-X | Malaise, Pancytopenia, Pulmonary Oedema, Renal Impairment
on Oct 19, 2009 Male patient from UNITED KINGDOM , 69 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: malaise, pancytopenia, pulmonary oedema, renal impairment. Methyldopa dosage: 500 Mg (3 In 1 D) Oral. During the same period patient was treated with ADCAL D3 (COLECALCIFEROL, CALCIUM CARBONATE) (COLECALCIFEROL, CALCIUM (View Adcal-d3 (colecalciferol, Calcium Carbonate) (colecalciferol, Calcium Review and Adcal-d3 (colecalciferol, Calcium Carbonate) (colecalciferol, Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ATORVASTATIN (ATORVASTATIN) (ATORVASTATIN) (View Atorvastatin (atorvastatin) (atorvastatin) Review and Atorvastatin (atorvastatin) (atorvastatin) Label ), CLOPIDOGREL HYDROGEN SULPHATE (CLOPIDOGREL) (CLOPIDOGREL) (View Clopidogrel Hydrogen Sulphate (clopidogrel) (clopidogrel) Review and Clopidogrel Hydrogen Sulphate (clopidogrel) (clopidogrel) Label ), DOXAZOSIN (DOXAZOSIN) (DOXAZOSIN) (View Doxazosin (doxazosin) (doxazosin) Review and Doxazosin (doxazosin) (doxazosin) Label ), FUROSEMIDE (FUROSEMIDE) (FUROSEMIDE) (View Furosemide (furosemide) (furosemide) Review and Furosemide (furosemide) (furosemide) Label ), ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITRATE) (ISOSORBIDE MONONITRAT (View Isosorbide Mononitrate (isosorbide Mononitrate) (isosorbide Mononitrat Review and Isosorbide Mononitrate (isosorbide Mononitrate) (isosorbide Mononitrat Label ). Patient was hospitalized.

6419186-2 | Systemic Lupus Erythematosus
Patient was taking Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: systemic lupus erythematosus on Oct 28, 2009 from UNITED STATES Additional patient health information: Female patient , 43 years of age, weighting 150.0 lb, was diagnosed with hypertension and. Methyldopa dosage: 25mg 2/day Po.

6380254-5 | Abortion Induced
Adverse event was reported on Sep 09, 2009 by a Female patient taking Methyldopa (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 25 years of age, Patient had the following side effects: abortion induced. During the same period patient was treated with HYDRALAZINE (HYDRALAZINE) (HYDRALAZONE) (View Hydralazine (hydralazine) (hydralazone) Review and Hydralazine (hydralazine) (hydralazone) Label ). Patient was hospitalized.

6299649-3 | Neonatal Respiratory Arrest, Tremor Neonatal
on Aug 05, 2009 Male patient from UNITED STATES , weighting 10.00 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: neonatal respiratory arrest, tremor neonatal. Methyldopa dosage: 1 Tablet Once/day Po. Patient was hospitalized.

6283434-2 | Headache, Hepatitis Acute, Liver Injury, Tachycardia
on Jul 21, 2009 Female patient from UNITED STATES , 43 years of age, was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hepatitis acute, liver injury, tachycardia. Methyldopa dosage: 125 Mg Po Twice Daily.

6283434-2 | Headache, Hepatitis Acute, Liver Injury, Tachycardia
Patient was taking Methyldopa (View Usage). Patient had the following side effects: headache (What is headache?), hepatitis acute, liver injury, tachycardia on Jul 21, 2009 from UNITED STATES Additional patient health information: Female patient , 43 years of age, . Methyldopa dosage: 125 Mg Po Twice Daily.

6282842-3 | Alanine Aminotransferase Increased, Antinuclear Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Jaundice, Liver Injury
Adverse event was reported on Jul 22, 2009 by a Female patient taking Methyldopa (View Usage) (Dosage: 250 Mg (1/2 To 1 Tab Po Bid)) . Location: UNITED STATES , 17 years of age, After Methyldopa was administered, patient had the following side effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice (What is jaundice?), liver injury. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6282842-3 | Alanine Aminotransferase Increased, Antinuclear Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Jaundice, Liver Injury
on Jul 22, 2009 Female patient from UNITED STATES , 17 years of age, was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice (What is jaundice?), liver injury. Methyldopa dosage: 250 Mg (1/2 To 1 Tab Po Bid). During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6252188-8 | Blood Bilirubin Unconjugated Increased, Caesarean Section, Cystitis Klebsiella, Jaundice Neonatal, Laboratory Test Abnormal, Platelet Count Increased
on Jun 15, 2009 Female patient from TURKEY , weighting 5.73 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: blood bilirubin unconjugated increased, caesarean section, cystitis klebsiella, jaundice neonatal, laboratory test abnormal, platelet count increased. Methyldopa dosage: (250 Mg Bid).

6096657-2 | Anaemia, Dialysis, Gastric Cancer, Malaise
Patient was taking Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: anaemia, dialysis (What is dialysis?), gastric cancer, malaise on Feb 10, 2009 from JAPAN Additional patient health information: Male patient , 78 years of age, was diagnosed with hypertension and. Methyldopa dosage: 250 Mg Po. During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), DIGESTIVE MEDICINE (View Digestive Medicine Review and Digestive Medicine Label ). Patient was hospitalized.

6078568-1 | Blood Pressure Inadequately Controlled, Caesarean Section, Premature Labour
Adverse event was reported on Jan 27, 2009 by a Female patient taking Methyldopa (View Usage) (Dosage: 750 Mg Po) was diagnosed with hypertension and. Location: BELGIUM , 25 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, caesarean section, premature labour. During the same period patient was treated with LABETALOL HYDROCHLORIDE (300 Mg Po) (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ), URAPIDIL (240 Mg/2400 Mg Iv) (View Urapidil Review and Urapidil Label ). Patient was hospitalized.

6074649-7 | Acute Hepatic Failure, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Pressure Increased, Hepatic Necrosis, Klebsiella Sepsis, Liver Transplant, Multi-organ Failure
on Feb 09, 2009 Female patient from UNITED STATES , 37 years of age, weighting 332.0 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: acute hepatic failure, alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood pressure increased, hepatic necrosis, klebsiella sepsis, liver transplant (What is liver transplant?), multi-organ failure. Methyldopa dosage: 250 Mg Tid Po.

6073984-6 | Back Pain, Chest Pain, Hypoaesthesia, Muscular Weakness
on Feb 09, 2009 Female patient from UNITED STATES , 32 years of age, weighting 157.0 lb, was diagnosed with prehypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: back pain (What is back pain?), chest pain (What is chest pain?), hypoaesthesia, muscular weakness. Methyldopa dosage: 250mg Bid Po.

6070392-9 | Amniotic Fluid Volume Decreased, Foetal Growth Retardation
Patient was taking Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: amniotic fluid volume decreased, foetal growth retardation on Jan 15, 2009 from CANADA Additional patient health information: Female patient , 20 years of age, was diagnosed with hypertension and. Methyldopa dosage: Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6055700-7 | Lymphoma, Toxic Skin Eruption
Adverse event was reported on Jan 14, 2009 by a Female patient taking Methyldopa (View Usage) (Dosage: 250 Mg, Po) was diagnosed with hypertension and. Location: FRANCE , 94 years of age, Patient had the following side effects: lymphoma (What is lymphoma?), toxic skin eruption. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ).

6052559-9 | Blood Albumin Decreased, Caesarean Section, Glomerulonephritis Acute, Haematocrit Decreased, Haemodialysis, Haemoglobin Decreased, Hypertension, International Normalised Ratio Decreased, Oedema Peripheral
on Jan 05, 2009 Female patient from UNITED STATES , 32 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: blood albumin decreased, caesarean section, glomerulonephritis acute, haematocrit decreased, haemodialysis, haemoglobin decreased, hypertension, international normalised ratio decreased, oedema peripheral. Methyldopa dosage: 500 Mg, Bid; Po. Patient was hospitalized.

6026307-2 | Abortion Induced, Anaemia, Blood Lactate Dehydrogenase Increased, Blood Pressure Fluctuation, Caesarean Section, Disease Progression, Disease Recurrence
on Nov 18, 2008 Female patient from HUNGARY , 33 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, anaemia, blood lactate dehydrogenase increased, blood pressure fluctuation, caesarean section, disease progression, disease recurrence. Methyldopa dosage: 1000 Mg Po. During the same period patient was treated with CLOPAMIDE (View Clopamide Review and Clopamide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METHYLPREDNISONE SODIUM SUCCINATE (View Methylprednisone Sodium Succinate Review and Methylprednisone Sodium Succinate Label ). Patient was hospitalized.

6026306-0 | Gastrointestinal Disorder, Hepatitis, Malaise
Patient was taking Methyldopa (View Usage). Patient had the following side effects: gastrointestinal disorder, hepatitis (What is hepatitis?), malaise on Dec 16, 2008 from FRANCE Additional patient health information: Female patient , 29 years of age, was diagnosed with prophylaxis and. Methyldopa dosage: 500 Mg/250 Mg, Po. Patient was hospitalized.

5987487-8 | Heart Rate Increased, Hydrops Foetalis, Hypertensive Crisis, Phaeochromocytoma
Adverse event was reported on Nov 17, 2008 by a Female patient taking Methyldopa (View Usage) (Dosage: 750 Mg, Po) was diagnosed with hypertension and. Location: INDIA , 26 years of age, After Methyldopa was administered, patient had the following side effects: heart rate increased, hydrops foetalis, hypertensive crisis, phaeochromocytoma. During the same period patient was treated with NIFEDIPINE (15 Mg, Po) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

5985135-4 | Abortion Induced, Blood Pressure Inadequately Controlled, Hellp Syndrome, Left Ventricular Hypertrophy, Multi-organ Disorder, Oedema Peripheral, Oliguria, Renal Artery Stenosis
on Jul 26, 2007 Female patient from UNITED STATES , 24 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, blood pressure inadequately controlled, hellp syndrome, left ventricular hypertrophy, multi-organ disorder, oedema peripheral, oliguria, renal artery stenosis. Methyldopa dosage: . During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

5963045-6 | Apgar Score Low, Base Excess Negative, Blood Ph Decreased, Blood Pressure Inadequately Controlled, Caesarean Section, Foetal Growth Retardation, Neonatal Disorder, Premature Baby
on Oct 27, 2008 Female patient from JAPAN , 30 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: apgar score low, base excess negative, blood ph decreased, blood pressure inadequately controlled, caesarean section, foetal growth retardation, neonatal disorder, premature baby. Methyldopa dosage: Po. During the same period patient was treated with LABETALOL HYDROCHLORIDE (Po) (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ), HYDRALAZINE HYDROCHLORIDE (View Hydralazine Hydrochloride Review and Hydralazine Hydrochloride Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

5963038-9 | Toxic Skin Eruption
Patient was taking Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: toxic skin eruption on Nov 06, 2008 from FRANCE Additional patient health information: Female patient , 94 years of age, was diagnosed with hypertension and. Methyldopa dosage: 250 Mg, Po. During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5957640-8 | Apgar Score Low, Base Excess Negative, Blood Ph Decreased, Blood Pressure Inadequately Controlled, Caesarean Section, Foetal Growth Retardation, Premature Baby, Renal Impairment
Adverse event was reported on Oct 27, 2008 by a Female patient taking Methyldopa (View Usage) (Dosage: Po) was diagnosed with hypertension and. Location: JAPAN , 30 years of age, Patient experienced the following unwanted or unexpected effects: apgar score low, base excess negative, blood ph decreased, blood pressure inadequately controlled, caesarean section, foetal growth retardation, premature baby, renal impairment. During the same period patient was treated with LABETALOL HYDROCHLORIDE (Po) (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ), HYDRALAZINE HYDROCHLORIDE (View Hydralazine Hydrochloride Review and Hydralazine Hydrochloride Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

5920089-8 | Dyspnoea, Haemolytic Anaemia
on Sep 25, 2008 Female patient from FRANCE , 42 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: dyspnoea, haemolytic anaemia. Methyldopa dosage: Po. During the same period patient was treated with BLACK HOREHOUND (+) HAWTHORN (+) PASSION (View Black Horehound (+) Hawthorn (+) Passion Review and Black Horehound (+) Hawthorn (+) Passion Label ), GINKGO (+) HEPTAMINOL HYDROCHLORIDE (+) (View Ginkgo (+) Heptaminol Hydrochloride (+) Review and Ginkgo (+) Heptaminol Hydrochloride (+) Label ).

5912103-0 | Caesarean Section, Pre-eclampsia, Premature Baby, Small For Dates Baby
on Sep 23, 2008 Female patient from MEXICO , 38 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: caesarean section, pre-eclampsia, premature baby, small for dates baby. Methyldopa dosage: 1 Tablet , Po. During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), IRON POLYMALTOSE (View Iron Polymaltose Review and Iron Polymaltose Label ).

5901438-3 | Blood Pressure Inadequately Controlled, Caesarean Section, Condition Aggravated, Foetal Distress Syndrome, Foetal Hypokinesia, Hypertensive Nephropathy, Iga Nephropathy
Patient was taking Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, caesarean section, condition aggravated, foetal distress syndrome, foetal hypokinesia, hypertensive nephropathy, iga nephropathy on Sep 10, 2008 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with hypertension and. Methyldopa dosage: 1500 Mg/daily Po, 375 Mg/daily Po.

5899524-X | Condition Aggravated, Deafness, Dysgeusia
Adverse event was reported on Sep 11, 2008 by a Female patient taking Methyldopa (View Usage) (Dosage: 500 Mg/daily, Po, 750 Mg/daily, Po) . Location: JAPAN , 70 years of age, Patient had the following side effects: condition aggravated, deafness, dysgeusia.

5706128-8 | Insomnia, Restlessness
on Apr 08, 2008 Male patient from NETHERLANDS , weighting 13.23 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: insomnia, restlessness. Methyldopa dosage: . Patient was hospitalized.

5691715-6 | Insomnia, Restlessness
on Mar 24, 2008 Male patient from NETHERLANDS , weighting 13.23 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia, restlessness. Methyldopa dosage: . Patient was hospitalized.

5469555-2 | Blood Bilirubin Increased, Faeces Pale, Hepatic Enzyme Increased, Ocular Icterus, Urine Colour Abnormal, Yellow Skin
Patient was taking Methyldopa (View Usage). Patient had the following side effects: blood bilirubin increased, faeces pale, hepatic enzyme increased, ocular icterus, urine colour abnormal, yellow skin on Sep 25, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 220.0 lb, was diagnosed with eclampsia, hypertension and. Methyldopa dosage: 500 Mg 2 Daily Po.

5375988-5 | Abortion Spontaneous, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Hepatitis C Positive, Liver Disorder
Adverse event was reported on Jun 27, 2007 by a Female patient taking Methyldopa (View Usage) (Dosage: ) . Location: UNITED STATES , 28 years of age, After Methyldopa was administered, patient had the following side effects: abortion spontaneous, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood pressure increased, hepatitis c positive, liver disorder.

5236589-2 | Cerebrovascular Accident
on Nov 17, 2006 Female patient from UNITED STATES , 58 years of age, was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Methyldopa dosage: 500 Mg (250 Mg, 2 In 1 D), Oral.

5209089-3 | Condition Aggravated, Dehydration, Hypertension, Hypertensive Crisis, Thrombocytopenia
on Dec 29, 2006 Female patient from CANADA , 58 years of age, weighting 240.3 lb, was treated with Methyldopa (View Usage). Patient had the following side effects: condition aggravated, dehydration, hypertension, hypertensive crisis, thrombocytopenia. Methyldopa dosage: . During the same period patient was treated with SU011248 (SUNITINIB MALATE) (See Image) (View Su011248 (sunitinib Malate) Review and Su011248 (sunitinib Malate) Label ). Patient was hospitalized.

5146794-1 | Condition Aggravated, Dehydration, Hypertension
Patient was taking Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: condition aggravated, dehydration, hypertension on Oct 18, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 240.3 lb, . Methyldopa dosage: . During the same period patient was treated with SU011248 (SUNITINIB MALATE) (See Image) (View Su011248 (sunitinib Malate) Review and Su011248 (sunitinib Malate) Label ). Patient was hospitalized.

5133999-9 | Headache, Palpitations
Adverse event was reported on Oct 23, 2006 by a Female patient taking Methyldopa (View Usage) (Dosage: 2 Tabs Tid Po) was diagnosed with hypertension and. Location: UNITED STATES , 42 years of age, weighting 130.0 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), palpitations.

5096854-9 | Hepatitis Acute
on Sep 01, 2006 Female patient from UNITED STATES , weighting 183.0 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). Patient had the following side effects: hepatitis acute. Methyldopa dosage: 250 Mg Twice Daily Oral.

5040245-3 | Induced Labour, Pre-eclampsia, Pregnancy Induced Hypertension, Premature Labour
on Nov 18, 2005 Female patient from UNITED STATES , 34 years of age, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: induced labour, pre-eclampsia, pregnancy induced hypertension, premature labour. Methyldopa dosage: Unk, Tid. During the same period patient was treated with PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ), LOTREL (View Lotrel Review and Lotrel Label ).

5034635-2 | Congenital Cytomegalovirus Infection, Deafness Neurosensory, Dilatation Ventricular, Neonatal Disorder, Parotitis, Staphylococcal Infection
Patient was taking Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: congenital cytomegalovirus infection, deafness neurosensory, dilatation ventricular, neonatal disorder, parotitis, staphylococcal infection (What is staphylococcal infection?) on Jun 05, 2006 from JAPAN Additional patient health information: Male patient , weighting 5.84 lb, . Methyldopa dosage: Var Qday Po. Patient was hospitalized and became disabled.

5031621-3 | Induced Labour, Pre-eclampsia, Premature Labour
Adverse event was reported on Nov 18, 2005 by a Female patient taking Methyldopa (View Usage) (Dosage: Unk, Tid) was diagnosed with hypertension and. Location: UNITED STATES , 34 years of age, Patient had the following side effects: induced labour, pre-eclampsia, premature labour. During the same period patient was treated with PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ), LOTREL (10/20mg) (View Lotrel Review and Lotrel Label ).

5015961-X | Headache, Hypertension
on May 31, 2006 Female patient from UNITED STATES , 36 years of age, weighting 305.0 lb, was diagnosed with hypertension and was treated with Methyldopa (View Usage). After Methyldopa was administered, patient had the following side effects: headache (What is headache?), hypertension. Methyldopa dosage: 500 Mg Twice Daily Po. During the same period patient was treated with VITAMIN AND MINERAL PRENATAL SUPPLEMENT W/ FOLIC ACID CAP (View Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Review and Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

5002748-7 | Malaise, Periorbital Oedema, Thirst, Visual Acuity Reduced
on May 11, 2006 Female patient from AUSTRALIA , weighting 121.3 lb, was diagnosed with ill-defined disorder, essential hypertension and was treated with Methyldopa (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, periorbital oedema, thirst, visual acuity reduced. Methyldopa dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 2 Milligram(s)) (View Coversyl Review and Coversyl Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SLOW K (View Slow-k Review and Slow-k Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ). Patient was hospitalized.

4712888-5 | Confusional State, Dysarthria
Patient was taking Methyldopa (View Usage). Patient had the following side effects: confusional state, dysarthria on Jul 12, 2005 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 154.1 lb, was diagnosed with hypertension and. Methyldopa dosage: 500 Mg Twice Daily Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), OSCAL (View Oscal Review and Oscal Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ARANESP (View Aranesp Review and Aranesp Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), LANTUS (View Lantus Review and Lantus Label ).